Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
absent, accommodate, accused, add, adequacy, alerting, Alexander, anesthesiologist, Annex, Antigen, arbitrage, Arm, assemble, attendant, batch, Biden, bilateral, bilaterally, black, boost, box, Brazil, Britain, Carolina, CEO, certified, chain, Chancery, cheaper, Chimeric, clock, CMDh, Commerce, Commissioner, compassionate, concept, constantly, contrary, cooperation, CPRA, credential, culture, Cut, cyber, cybersecurity, Daiichi, Dawn, Deal, declaratory, dedicated, destruction, discourage, diverge, divergence, DME, doctrine, dossier, Durham, duty, EEA, EFTA, EHS, eighteen, eighty, embodied, embodying, empower, England, entertain, EOS, essential, exceptionally, exhaustive, expiry, extra, facially, faster, FDPIC, fear, feasible, feel, female, fiduciary, fifty, Fisher, fit, formal, forty, forum, foster, foundation, fourteen, Friedrich, FTC, fundamental, Geral, Graybug, Great, greatest, Handbook, harmonize, headcount, hijacking, home, HTA, Iceland, immunologic, imperative, inapplicable, incumbent, indemnity, INFINITY, inflating, inquiry, inseverability, inseverable, inspired, intranet, intraocular, Johnson, Justice, kind, Kodiak, largest, Lexeo, LGPD, Liechtenstein, lifespan, Lifetime, lodge, MA, magnitude, malware, meantime, mediated, mental, missed, missing, mission, misuse, modestly, month, NaN, NCA, nineteen, Norway, notification, nurse, official, overhaul, owner, pandemic, parallel, paramount, Passage, password, perspective, phishing, prioritize, prioritized, QD, randomized, ransomware, reassessment, Receptor, recession, reconsider, redirect, Reed, reelection, reevaluation, referenced, referencing, regime, relief, reminiscent, remote, rentable, rescind, residency, resume, retested, retirement, reward, Rocket, RP, Sangamo, Sankyo, Scotland, sequester, session, Seventeen, sham, shell, Shield, sickle, simultaneously, Sio, slate, SmPC, social, societal, software, South, spectral, staffing, straddling, stronger, strongly, stuffing, subsided, supervisory, Supplementary, surgery, talent, Taysha, theft, thickening, thirty, threaten, transforming, transposed, travel, treatable, Tuckson, TW, unbilled, undermine, underrepresented, unduly, unexercised, unfair, unilaterally, unique, unlimited, unmasked, unsure, upholding, vaccine, venue, verifiable, vigorously, vitrectomy, vivo, warm, whistleblower, withdrew, workplace
Removed:
aimed, Allergan, angioedema, antitrypsin, arrangement, attest, Australia, bind, BioMarin, Cadillac, ceased, cGMP, Chairman, choroidal, circumvent, close, comment, compensatory, computer, conclusive, Concurrently, conditional, confirmed, consequentially, contingency, counterclaim, devoted, disaster, electrical, episome, escalation, FA, figure, French, GlaxoSmithKline, HITECH, importation, index, Inserm, insured, interpret, involuntary, Irish, irrespective, language, Likewise, liver, loosen, malfeasance, manmade, marking, Menlo, mice, minimal, modulate, mouse, NHP, nonexclusively, occupy, Park, partnered, permeability, perpetual, personally, petition, plc, predominantly, Presidential, provisional, reimbursable, remediate, retrospective, RMS, Sanofi, selecting, separation, serving, subsidiary, Switching, systemic, telecommunication, terrorism, Transfert, Trump, unit, vascular, vectorology, voretigene, Voyager, war, water
Filing tables
Filing exhibits
Related press release
Associated ADVM transcripts
ADVM similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1)Registration Statements on Form S-8 Nos. 333-223894, 333-218465, 333-211439, 333-203398, 333-199296, 333-230138, 333-233135, 333-220894, 333-237136 and 333-243761
(2)Registration Statements on Form S-3 Nos. 333-219890 and 333-233134
of our reports dated March 1, 2021, with respect to the consolidated financial statements of Adverum Biotechnologies Inc. and the effectiveness of internal control over financial reporting of Adverum Biotechnologies, Inc. included in this Annual Report (Form 10-K) of Adverum Biotechnologies Inc. for the year ended December 31, 2020.
/s/ Ernst & Young LLP
San Jose, California
March 1, 2021